iSpecimen and myOnsite Deploy Mobile Phlebotomy During Coronavirus Pandemic


Applied Clinical Trials

iSpecimen has announced a new initiative in the battle against COVID-19 and other diseases, mobile phlebotomy support that will bring at-home sample collection to patients and donors interested in advancing research. The mobile service extends iSpecimen’s ongoing mission to advance medical research by connecting researchers with patients, biospecimens, and the data they need to perform their work.

For more information, click here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.